Music Intervention for Muscular Dystrophy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test whether Dalcroze music education can help children with a specific type of muscular dystrophy called DM1. It examines whether weekly music sessions are feasible and comfortable for these children and assesses if the music can improve their brain and heart symptoms. Children aged 6 to 18 with confirmed congenital or infantile-onset DM1 who can maintain their current medication might be suitable candidates. Participants will attend music sessions, participate in assessments, and wear devices to track their progress. The trial will also gather feedback from parents to evaluate the practicality of this music approach. As an unphased trial, this study provides a unique opportunity for children to explore the potential benefits of music education in managing DM1 symptoms.
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. Participants are required to stay on stable medication from the day of screening to the end of the study.
What prior data suggests that this music intervention is safe for children with DM1?
Studies have shown that Dalcroze music education is generally easy for participants to handle, including those with special educational needs. Research indicates that this music-and-movement approach can lead to positive results, with most studies reporting benefits and only a few noting issues like low participation rates. Reports of serious side effects linked to this method are absent, suggesting it is safe for use in this trial. Participants in the study will engage in music sessions designed to be both fun and easy to manage, further supporting its ease of use.12345
Why are researchers excited about this trial?
Unlike standard treatments for muscular dystrophy, which often focus on medication and physical therapy, the Dalcroze music education intervention takes a unique approach by integrating music and movement. This method is believed to enhance motor skills and coordination through rhythm and improvisation, offering a holistic benefit that traditional therapies might not address. Researchers are excited about this treatment because it could provide a non-invasive, enjoyable, and supportive therapy option that complements existing care, potentially improving quality of life for individuals with muscular dystrophy.
What evidence suggests that Dalcroze music education is effective for improving brain and heart symptoms in children with DM1?
Research has shown that activities combining music and movement, such as Dalcroze music education, can benefit individuals with brain-heart disorders. Most studies report positive results, although some faced challenges with participant adherence. Dalcroze music education uses body movement to connect with music, enhancing coordination and cognitive skills. While limited data exists on children with congenital myotonic dystrophy (DM1), this method has proven beneficial for other groups. Early findings suggest it might alleviate both brain and heart symptoms in DM1 by engaging the whole body and mind. In this trial, participants will attend weekly Dalcroze music education sessions to explore its potential benefits for DM1.12678
Are You a Good Fit for This Trial?
This trial is for children with congenital Myotonic Dystrophy Type 1 (DM1) who have brain and heart symptoms. They must be able to attend weekly music sessions for 10 weeks, provide biological samples, and use wearable devices for monitoring. Parents should also participate in questionnaires and focus groups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 45-minute-long music sessions once weekly for 10 weeks and provide biological samples
Follow-up
Participants are monitored for changes in physical and cognitive assessments, and qualitative feedback is collected
Extension
Participants may continue to use wearable devices for extended monitoring of brain-heart biomarkers
What Are the Treatments Tested in This Trial?
Interventions
- Dalcroze music education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hanns Lochmuller
Lead Sponsor
University of Ottawa
Collaborator